Under-representation of the elderly in cancer clinical trials.
Cancer predominantly affects the elderly, but those over 65 years of age are significantly and consistently under-represented in clinical trials of potential new treatments. How important is this to cancer care in the elderly, are there identifiable reasons for the disparity and can anything be done to redress the imbalance?
Department of Medicine, Princess Royal University Hospital, Kent.
Kathryn J
KJ
Lang
Surjit
S
Lidder
D000367:Age Factors; D000368:Aged; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D002986:Clinical Trials as Topic; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D018579:Patient Selection